Quick Search

 

 


 

 

Result Summary for 101468/162

Result Summary
Protocol ID: 101468/162
Clinical Study ID: SKF-101468/162
Official Title: A four-way cross-over, placebo- and standard formulation -controlled study to compare the single-dose pharmacokinetics of ropinirole from new formulations and from the standard formulation in healthy male and female volunteers
Phase: Phase 1
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: requip;requip
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.